$527 Million is the total value of SECTOR GAMMA AS's 26 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 28.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LLY | Buy | LILLY ELI & CO | $72,050,000 | +29.7% | 914,920 | +18.6% | 13.68% | +19.6% |
BAX | Sell | BAXTER INTL INC | $48,790,000 | -2.5% | 1,078,943 | -11.4% | 9.26% | -10.0% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $33,002,000 | -0.7% | 1,412,170 | -20.0% | 6.26% | -8.4% |
PKI | Buy | PERKINELMER INC | $28,501,000 | +15.5% | 543,710 | +9.0% | 5.41% | +6.5% |
SHPG | Buy | SHIRE PLCsponsored adr | $28,051,000 | +20.3% | 152,386 | +12.3% | 5.32% | +10.9% |
IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $26,300,000 | +29.5% | 329,657 | +9.4% | 4.99% | +19.5% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $24,007,000 | +45.0% | 279,083 | +34.0% | 4.56% | +33.8% |
BIIB | Buy | BIOGEN IDEC INC | $23,382,000 | +9.7% | 96,690 | +18.0% | 4.44% | +1.2% |
IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $23,134,000 | -15.0% | 1,769,368 | -28.8% | 4.39% | -21.6% |
STJ | Sell | ST JUDE MED INC | $20,141,000 | -22.7% | 258,214 | -45.5% | 3.82% | -28.7% |
PDCO | Buy | PATTERSON COMPANIES INC | $19,963,000 | +29.5% | 416,844 | +25.8% | 3.79% | +19.5% |
MASI | Buy | MASIMO CORP | $18,488,000 | +38.8% | 352,053 | +10.5% | 3.51% | +28.0% |
BIO | Sell | BIO RAD LABS INCcl a | $18,467,000 | +1.7% | 129,124 | -2.7% | 3.51% | -6.1% |
ABT | New | ABBOTT LABS | $17,147,000 | – | 436,200 | +100.0% | 3.26% | – |
EXEL | New | EXELIXIS INC | $16,087,000 | – | 2,059,833 | +100.0% | 3.05% | – |
MCK | Sell | MCKESSON CORP | $14,749,000 | +5.8% | 79,020 | -10.9% | 2.80% | -2.4% |
MRK | Sell | MERCK & CO INC NEW | $14,267,000 | -37.9% | 247,650 | -43.0% | 2.71% | -42.7% |
CI | Buy | CIGNA CORPORATION | $14,062,000 | +2.9% | 109,870 | +10.3% | 2.67% | -5.1% |
BMY | Sell | BRISTOL MYERS SQUIBB CO | $13,791,000 | -34.3% | 187,500 | -43.0% | 2.62% | -39.4% |
ANTM | New | ANTHEM INC | $13,699,000 | – | 104,300 | +100.0% | 2.60% | – |
MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $9,882,000 | +37.1% | 914,979 | +17.3% | 1.88% | +26.4% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $8,603,000 | +28.2% | 81,224 | +34.9% | 1.63% | +18.2% |
OMI | Sell | OWENS & MINOR INC NEW | $7,564,000 | -15.4% | 202,342 | -8.5% | 1.44% | -22.0% |
IPXL | New | IMPAX LABORATORIES INC | $6,742,000 | – | 233,934 | +100.0% | 1.28% | – |
THC | Buy | TENET HEALTHCARE CORP | $5,398,000 | +4.5% | 195,300 | +9.4% | 1.02% | -3.6% |
SPPI | Sell | SPECTRUM PHARMACEUTICALS INC | $485,000 | -4.2% | 73,810 | -7.3% | 0.09% | -11.5% |
WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -92,115 | -100.0% | -1.76% | – |
BXLT | Exit | BAXALTA INC | $0 | – | -356,310 | -100.0% | -2.96% | – |
MDVN | Exit | MEDIVATION INC | $0 | – | -385,923 | -100.0% | -3.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.